TABLE 2.
Characteristic | No. of P. vivax isolates | Results |
---|---|---|
Parasitemia (no. of asexual parasites/μl) | 51 | Geometric mean, 7,561 (95% CI, 4,944–10,179) |
Proportion of parasites at ring stage | 29a | Median, 94% (range, 78%–100%) |
Delay from venipuncture to processing | 29 | Median, 120 min (range, 50–225 min) |
Duration of the drug assay | 29 | Median, 46 h (range, 25–54 h) |
Schizont count at assay harvest | 29 | Mean, 40 (95% CI, 38.0–41.5) |
Number of isolates with ≥70% ring-stage parasites at the start of the ex vivo drug susceptibility assay.